PICARD MEDICAL INC PMI
ASignal's systematic analysis rates PMI as Bearish.
Reflects the latest available analysis · analyzed Nov 13, 2026
The case on PMI
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- High revenue growth (38.6%) indicating strong top-line expansion
- Low debt-to-equity ratio (0.92x) suggesting manageable leverage
- Growth score of 0.9 reflects strong forward revenue momentum
- Negative operating margin (-248.09%) signaling severe profitability issues
- Negative return on assets (-93.61%) and negative EV/EBITDA (-1.29x) indicating financial distress
- Extremely low quick ratio (0.09x) raising liquidity concerns
- MACD below signal line and declining momentum
- Price below 20-day and 50-day moving averages suggesting downtrend
See the full verdict on PMI
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes PMI
Most investors never get a second opinion, let alone several. ASignal runs PMI past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.